These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4272950)

  • 21. Effect of brinase and thrombolysin on the electrochemical, nature of the cardiovascular system of experimental animals (dogs and rabbits).
    Sawyer PN
    Thromb Res; 1977 Mar; 10(3):531-6. PubMed ID: 140475
    [No Abstract]   [Full Text] [Related]  

  • 22. [Fibrinolytic activity of a protease isolated from Aspergillus ochraceus].
    Klöcking HP; Markwardt F
    Acta Biol Med Ger; 1971; 26(1):35-44. PubMed ID: 5103710
    [No Abstract]   [Full Text] [Related]  

  • 23. Proteinases and proteinase inhibitors in experimental shock states.
    Back N; Wilkens H; Steger R
    Ann N Y Acad Sci; 1968 Jun; 146(2):491-516. PubMed ID: 5305811
    [No Abstract]   [Full Text] [Related]  

  • 24. Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects.
    Ogston D; Douglas AS
    Drugs; 1971; 1(3):228-46. PubMed ID: 4256645
    [No Abstract]   [Full Text] [Related]  

  • 25. [In vitro and in vivo thromboelastographic studies of blood coagulation changes using cobalt (II) ions].
    Fiedler H; Taube C
    Z Gesamte Inn Med; 1970 Apr; 25(8):357-62. PubMed ID: 5523262
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on the proteolysis of fibrinogen and fibrin by Aspergillus ochraceus enzyme as compared to the action of plasmin.
    Teisseyre E; Latallo ZS; Kopeć M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(1):99-110. PubMed ID: 4134484
    [No Abstract]   [Full Text] [Related]  

  • 27. On the rates of coagulation and subsequent softening of bovine and human blood and of thrombin-fibrinogen.
    Blair GW; Burnett J
    Biorheology; 1968 Jul; 5(2):163-76. PubMed ID: 5737674
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular composition and biological properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU; Hansen MS; Smith GF; Latallo ZS; Chang ML; Mattler LE
    Ser Haematol; 1973; 6(4):494-512. PubMed ID: 4277578
    [No Abstract]   [Full Text] [Related]  

  • 29. Theoretical and practical (clinical) considerations concerning proteolytic enzymes and their inhibitors with particular reference to changes in the plasminogen-plasmin system observed during assisted circulation in man.
    Gans H; Subramanian V; John S; Castaneda AR; Lillehei CW
    Ann N Y Acad Sci; 1968 Jun; 146(2):721-36. PubMed ID: 4239441
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of various proteolytic enzymes on fibrinogen.
    Latallo ZS; Teisseyre E; Wegrzynowicz Z; Kopec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(2):158-66. PubMed ID: 4106004
    [No Abstract]   [Full Text] [Related]  

  • 31. ANTICOAGULANT ACTIVITY OF DIGEST PRODUCTS OF FIBRINOGEN BY PLASMIN.
    MAKI M; KIKUCHI I; MURAKAMI A
    Tohoku J Exp Med; 1964 Dec; 84():201-14. PubMed ID: 14242745
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of prothrombin and fibrinogen antisera on the clotting system of bovine blood].
    Kotschy M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(4):426-36. PubMed ID: 4121336
    [No Abstract]   [Full Text] [Related]  

  • 33. [Thrombolytic and pharmacodynamic properties of Aspergillus ochraceus protease].
    Klöcking HP; Markwardt F
    Farmakol Toksikol; 1975; 38(3):341-9. PubMed ID: 1084284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a protease inhibitor, ulinastatin, on coagulation and fibrinolysis in abdominal surgery.
    Nishiyama T; Yokoyama T; Yamashita K
    J Anesth; 2006; 20(3):179-82. PubMed ID: 16897236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Blood coagulating properties of immobilized proteases].
    Zubairov DM; Zinkevich OD
    Vopr Med Khim; 1976; 22(2):187-91. PubMed ID: 140525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of the purified thrombin-like enzyme and anticoagulant principle of Trimeresurus gramineus venom on blood coagulation in vivo.
    Outany C; Yun Yang F
    Toxicon; 1976; 14(3):197-201. PubMed ID: 941174
    [No Abstract]   [Full Text] [Related]  

  • 37. STUDY OF FIBRINOGEN TURNOVER RATES AFTER TOTAL HEPATECTOMY IN DOGS.
    GANS H
    Surgery; 1964 Apr; 55():544-50. PubMed ID: 14138019
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunological and hemocoagulative characteristics of serums of rabbits immunized with prothrombin, fibrinolysin (plasmin), fibrinogen and thrombin. (Experimental immuno-coagulopathy)].
    DE NICOLA P; ZANGAGLIA O; SOARDI F
    Riv Emoter Immunoematol; 1959; 6():161-78. PubMed ID: 13814944
    [No Abstract]   [Full Text] [Related]  

  • 39. Isolation and characterization of the thrombin-like enzyme from Cryptelytrops purpureomaculatus venom.
    Tan NH
    Comp Biochem Physiol C Toxicol Pharmacol; 2010 Jan; 151(1):131-6. PubMed ID: 19770070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombin and acetylated thrombin in the activation of fibrinolysis.
    Landaburu RH; Giavedoni E; Santillán R
    Can J Physiol Pharmacol; 1968 Nov; 46(6):809-13. PubMed ID: 5698925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.